MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Liabilities and Shareholders Equity (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Liabilities and Shareholders Equity came in at $244.4 million in Q4 2025, down 9.39% YoY from $269.8 million in Q4 2024, and up 29.01% on a QoQ basis from $189.5 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $244.4 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 9.39% year-over-year to $244.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $856.6 million (down 25.19% YoY) and the FY2025 annual result came in at $244.4 million, down 9.39% from the prior year.
  • Liabilities and Shareholders Equity advanced to $244.4 million in Q4 2025, from $189.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $326.7 million in Q4 2023 to a low of $1.7 million in Q1 2021.
  • A 5-year average of $163.6 million and a median of $211.4 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 19724.4% — and 2023, when it plunged 68.13%.
  • Tracing MGTX's Liabilities and Shareholders Equity over 5 years: stood at $320.2 million in 2021, then retreated by 0.6% to $318.2 million in 2022, then advanced by 2.67% to $326.7 million in 2023, then slipped by 17.44% to $269.8 million in 2024, then decreased by 9.39% to $244.4 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $244.4 million (Q4 2025), $189.5 million (Q3 2025), and $198.7 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 10.96 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.32 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 9.18 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.56 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.10 Bn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 3.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.26 Mn
Dec 31, 2025 244.43 Mn
Sep 30, 2025 189.47 Mn
Jun 30, 2025 198.72 Mn
Mar 31, 2025 224.01 Mn
Dec 31, 2024 269.75 Mn
Sep 30, 2024 299.49 Mn
Jun 30, 2024 266.65 Mn
Mar 31, 2024 309.24 Mn
Dec 31, 2023 326.74 Mn
Sep 30, 2023 267.19 Mn
Jun 30, 2023 2.39 Mn
Mar 31, 2023 288.14 Mn
Dec 31, 2022 318.24 Mn
Sep 30, 2022 7.60 Mn
Jun 30, 2022 7.48 Mn
Mar 31, 2022 8.57 Mn
Dec 31, 2021 7.18 Mn
Sep 30, 2021 4.03 Mn
Jun 30, 2021 3.18 Mn